Lookup NU author(s): Dr Margaret Piggott,
Emeritus Professor Elaine Perry,
Emeritus Professor Robert Perry
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The binding levels of [H-3]alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA), [H-3]kainate and [H-3](+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5,10 -1min (MK-801) were examined in human frontal cortex homogenates ranging from 24 weeks gestation to old age. Different developmental profiles were revealed for each ligand. [H-3]kainate binding peaked sharply in the neonate, declining precipitantly during the first year and returning to foetal levels by the first or second decade, with no further decline. [H-3]AMPA binding was also highest in the neonate, declining by the first decade to foetal levels and showing little or no further decline. [H-3]MK-801 binding in the presence of glutamate, glycine and spermidine rose sharply from the foetal and neonatal stages to peak from about 3 months of age, with elevated binding until the first or second decade and a subsequent decline throughout the whole age range. The pronounced developmental peak in [H-3]kainate binding implicates this receptor in the organisation of neuronal pathways, and in vulnerability to hypoxia and ischaemia at birth.
Author(s): Piggott MA, Perry EK, Perry RH, Scott D
Publication type: Article
Publication status: Published
Journal: Neuroscience Research Communications
Print publication date: 01/01/1993
ISSN (print): 0893-6609
ISSN (electronic): 1520-6769
Publisher: John Wiley & Sons Ltd